Monday, September 4, 2023

Neurogenic Shock in Spinal Cord Injury (SCI)

Hemodynamic management of acute spinal cord injury

1. Patients with traumatic aSCI (cervical or thoracic ASIA A-D) and central cord syndrome

2. MAP ≥ 85 mmHg for 5 days

3. Vasopressor agent:

     Norepinephrine (most patients)

     Dopamine (pts w bradycardia)

     Phenylephrine (more potential for harm in patients with bradycardia or heart failure)

     Epinephrine/vasopressin (use in refractory response only)

4. Arterial line if indicated

 

Hemodynamic management of acute spinal cord injury

Statement of Need

Perfusion & oxygen delivery is integral to prevent worsening of acute spinal cord injuries (aSCI).  Some patients with aSCI may exhibit hemodynamic instability due to damage to autonomic/sympathetic innervation pathways.  The published literature is weak in this area, which may result in variations in therapy.

Background

A mean arterial pressure (MAP) target of 85-90mmHg is suggested by guidelines to ensure adequate spinal perfusion after aSCI.(1-3)  Proactive hemodynamic management also reduces the risk of fluctuations in blood pressure, which may be deleterious after aSCI (particularly hypotension).(4)  Isotonic fluid resuscitation and the use of vasopressors may be needed to meet the target blood pressure in some individual.  Overall, the scientific support for the MAP target of >85mmHg is weak, consisting of under-powered, retrospective studies.  However, there is some consistency in these studies in that patients who consistently have a MAP >85mmHg seem to have better neurologic outcomes.(5-8)  Based on animal and human evidence, the level of evidence would be characterized as low to very low based on GRADE criteria.(9)  The literature primarily pertains to patients with traumatic injuries, rather than exacerbations of chronic spinal problems, though some of the same perfusion concerns may be applicable in these situations.

Recommendations

  1. Patients with traumatic aSCI
    1. Acute cervical or thoracic
    2. ASIA A-D
  2. Patients who exhibit a MAP < 85mmHg may require fluid management and/or vasopressors for hemodynamic support
    1. Isotonic fluids to ensure euvolemia should be initiated promptly (conditional recommendation, low level of evidence)
    2. Vasopressors may be considered to maintain MAP >85mmHg (conditional recommendation, low level of evidence)

                                                              i.      There is no literature to support a primary vasopressor of choice

                                                            ii.      Norepinephrine is a reasonable option for most patients with aSCI (conditional recommendation, low level of evidence)

                                                          iii.      Dopamine may be necessary in patients with bradycardia who need more chronotropic support (conditional recommendation, low level of evidence)

                                                          iv.      Phenylephrine is also reasonable to use as a primary or adjunct agent (conditional recommendation, low level of evidence)

1.      Phenylephrine has more potential for harm in patients with bradycardia or patients with heart failure

                                                            v.      Epinephrine, vasopressin should be used in situations of refractory response only (conditional recommendation, very low level of evidence)

    1. The duration of MAP targeting has commonly been described as 7 days (not to exceed) (conditional recommendation, low level of evidence)
  1. Consider continuous arterial blood pressure monitoring, particularly in the acute phases of care (good practice statement)

 

References

1.            Schroeder GD, Vaccaro AR, Welch WC. Best Practies Guidelines:  Spine Injury:  NEUROGENIC SHOCK AND SYSTEMIC PRESSURE-DIRECTED THERAPY. In: American College of Surgeons; 2022. p. 46-48.

2.            Early acute management in adults with spinal cord injury: a clinical practice guideline for health-care professionals. 2008;31(4):403-479.

3.            Cozzens JW, Prall JA, Holly L. The 2012 Guidelines for the Management of Acute Cervical Spine and Spinal Cord Injury. 2013;72 Suppl 2:2-3.

4.            Kong CY, Hosseini AM, Belanger LM, et al. A prospective evaluation of hemodynamic management in acute spinal cord injury patients. 2013;51(6):466-471.

5.            Weinberg JA, Farber SH, Kalamchi LD, et al. Mean arterial pressure maintenance following spinal cord injury: Does meeting the target matter? 2021;90(1):97-106.

6.            Vale FL, Burns J, Jackson AB, et al. Combined medical and surgical treatment after acute spinal cord injury: results of a prospective pilot study to assess the merits of aggressive medical resuscitation and blood pressure management. 1997;87(2):239-246.

7.            Hawryluk G, Whetstone W, Saigal R, et al. Mean Arterial Blood Pressure Correlates with Neurological Recovery after Human Spinal Cord Injury: Analysis of High Frequency Physiologic Data. 2015;32(24):1958-1967.

8.            Levi L, Wolf A, Belzberg H. Hemodynamic parameters in patients with acute cervical cord trauma: description, intervention, and prediction of outcome. 1993;33(6):1007-1016; discussion 1016-1007.

9.            Andrews JC, Schunemann HJ, Oxman AD, et al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. 2013;66(7):726-735.


Posted 9-4-23 Authors: Aaron Cook, PharmD, C Reynolds RN, A Bernard MD